- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 382.16M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $14.38B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $12.19B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.4B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.41B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.32B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.65B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.93B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.62B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $25.08B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $22.34B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $13.02B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $14.85B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $46.01B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $42.97B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 385.1M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $304M |
| Capex | Q1 2025 · Mar 31, 2024 | $167M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $204M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $2.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.07 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.84B |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $368M |
| Net Income | Q1 2025 · Mar 31, 2024 | $788M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $972M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $3.33B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.91B |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.24B |